SWGLH Whole Genome Sequencing Service

Whole Genome Sequencing (WGS) tests through the SWGLH

The GLH network has now launched WGS test for indications that are listed in the National Genomic Test Directory (NGTD):

• Eligible rare diseases
• Sarcoma
• Solid tumours in young people* both neurological and non- neurological
• Haematological malignancy, including in young people*

*Of note Young people include paediatric, teenagers and young adults up to the age of 25

Please follow the links below to access information relevant to your clinical area